GlaxoSmithKline Turns To AI For Drug Development

GSK AI Drug Development The Pharma giant- GlaxoSmithKline is ramping
up its use of artificial intelligence & would be recruiting 80
Artificial Intelligence specialists by the end of 2020. However, the
UK's largest drugmaker by revenue is struggling to hire Artificial
Intelligence scientists & engineers from areas such as Silicon Valley.
Therefore as an alternative, the drugmaker […]

The post GlaxoSmithKline Turns To AI For Drug Development appeared
first on BioTecNika .

https://www.biotecnika.org/2019/12/glaxosmithkline-turns-to-ai-for-drug-development/

Biotech News

Comments

Popular posts from this blog

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission

Biotecnika Times Newsletter 29.11.2021 NABI Research Training, National Cancer Tissue

Biotecnika Times – Newsletter 25.01.2021 – CSIR Notice, CSIR-CCMB & ILS Hiring, FSSAI Funded